Patent ID: 7939517
Filing Date: 2011-05-10
Classification: A61K

Abstract:
1. A method for treating a human male to increase athletic performance by increasing testosterone without causing concomitant reduction in endogenous estrogen levels comprising: orally administering to a human male to be treated an effective amount of at least one compound selected from the group consisting of: 1,4,6-androstatriene-3,17-dione; 1,4,6-androstatriene-3-one-17-ol; 1,4,6-androstatriene-3,17-diol; 1,4,6-androstatriene-3-ol-17-one; 1,4,6-androstatriene-3-one-17-azine; 1,4,6-androstatriene-17-one,3-azine; 1,4,6-androstatriene-3-ol-17-azine; and 1,4,6-androstatriene-17-ol-3-azine.